ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Viatris UK Limited – Reduced Wholesale Agreement

Manufacturer Agreements


Viatris UK Limited – Reduced Wholesale Agreement


Please read this communication carefully for information regarding an upcoming product ordering blackout period for Upjohn UK Ltd lines. Key details are:


  • – Customers will be unable to order the Upjohn UK Ltd product portfolio between 24th-31st December 2021. 

  • – Impacted products will be available for order from 1st January 2022 for delivery from 4th January 2022.

  • – List of impacted products included below in Appendix 1.


From 1st January 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply the Viatris UK Limited (“Viatris”) product portfolio to all pharmacies, hospitals and dispensing doctors in the UK including Northern Ireland.


To view the full Viatris product portfolio please click here


With effect from 1st January 2022, the business of Upjohn UK Limited (“Upjohn”) will be transferred to Viatris (formerly Mylan UK Healthcare Limited), so that all UK Viatris commercial activities operate under a single legal trading entity. Upjohn will cease to trade from this date. As a result of this change customers will be unable to order the Upjohn product portfolio impacted by this blackout period between 24th-31st December 2021. All affected products are highlighted in the above product list.


Final orders for these products will be your standard cut-off time on the evening of Thursday 23rd December for AM delivery on the 24th December. Following the morning deliveries on 24th December 2021 Upjohn will cease Direct to Pharmacy sales and transition to a Reduced Wholesaler Model through Viatris. Customers will be able to place orders for the impacted lines with Alliance Healthcare from 1st January 2022 for delivery from 4th January 2022.


Viatris have recently shared their own communication on this change advising you to ensure you have stock available within your pharmacies to cover any demand of the impacted products until the end of December 2021. Please click here to view this communication. The purchase, supply and distribution of all other Viatris products will remain unchanged, and will continue to be available through their existing supply arrangements both through this transition and from 1st January 2022.


From 1st January 2022, purchases of these lines will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will be subject to Alliance Healthcare’s low spend surcharge.


To receive the products from 1st January 2022, you can simply order from Alliance Healthcare in your usual manner. These products will be available on a same day delivery service.


If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.